BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4041165)

  • 1. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H; Odachi M; Kagawa S; Kurokawa K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complete response of lung metastasis from bladder cancer by combination chemotherapy with methotrexate, epirubicin and cisplatin: a case report].
    Oouchi H; Noguchi S; Masuda M; Shuin T; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1995 Mar; 41(3):227-30. PubMed ID: 7741078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
    Fukuoka H; Takeda M; Nomura S; Ogawa T; Sakanishi S
    Hinyokika Kiyo; 1991 May; 37(5):541-4. PubMed ID: 1858591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complete remission of brain metastasis of bladder cancer treated by M-VAC therapy].
    Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K
    Hinyokika Kiyo; 1989 Feb; 35(2):333-5. PubMed ID: 2735244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
    Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O; Yoshimura N; Taniguchi T; Nishimura K; Nakagawa T
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
    Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complete remission of recurrent ovarian dysgerminoma obtained by combined chemotherapy with cisplatin, adriamycin and cyclophosphamide].
    Yokota H; Saito M; Tsunoda H; Kawagoe K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):151-4. PubMed ID: 4038447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
    Hara Y; Kobayashi Y; Goto K; Tozuka K; Tokue A; Mochizuki M
    Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K; Nakame Y; Horiuchi S; Kaneoya F; Kuroda T; Tanoiri A; Koizumi M; Takahashi M; Negishi T; Saitoh H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
    Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K; Matsumoto K; Takai K; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
    Boccon-Gibod L; Guinet F; Cressey-Kanoui C; Debré B; Steg A
    Ann Urol (Paris); 1985; 19(4):239-43. PubMed ID: 4040730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.